Germinomatous Germ Cell Tumor
1 clinical trials · Condition
◉ Watch Germinomatous Germ Cell Tumor
| Record | Firm | Date |
|---|---|---|
| Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors (NCT03158064) | Memorial Sloan Kettering Cancer Center | 2017-05-15 |
Track Germinomatous Germ Cell Tumor automatically
Every clearance here is in the API, with alerts when new ones post.